Tag: “Sector”

Manchester United shares jumped on Tuesday, having surged as much as 30% in premarket trading, after Qatari media suggested Sheikh Jassim bin Hamad al-Thani was likely to succeed with his takeover bid.

Shares of Japanese automaker Toyota spiked 5% Tuesday after the company announced it will introduce a full lineup of battery electric vehicles with “next generation” batteries from 2026

The Federal Trade Commission is set to file for an injunction Monday seeking to block Microsoft’s proposed acquisition of Activision Blizzard, a person familiar with the matter told CNBC.

Synthesia, a digital media platform that lets users create artificial intelligence-generated videos, has raked in $90 million from investors — including U.S. chip giant Nvidia, the company told CNBC exclusively.

Advanced Micro Devices on Tuesday is expected to reveal new details about an AI “superchip” that analysts believe will be a strong challenger to Nvidia Corp, whose chips dominate the fast-growing artificial intelligence market.

U.S. grains merchant Bunge and Glencore -backed Viterra are merging to create an agricultural trading giant worth about $34 billion including debt, the companies said on Tuesday, in a deal that will likely draw close regulatory scrutiny.

The investor frenzy over artificial intelligence may reach a crescendo yet with the initial public offering of Arm Holdings. There are signs that the high-tech chip designer is readying for a listing as the market reaches peak hype.

Alzheimer’s disease experts in Europe weighing potential use of a new drug from Eisai and Biogen say its ability to slow cognitive decline may not outweigh its health risks, or be worth the toll on scarce healthcare resources.

After big stock rallies in shares of Tesla and Nvidia, Cathie Wood’s ARK Invest is taking some profits.

Τη συσχέτιση της επενδυτικής βαθμίδας με την απόδοση των τραπεζικών μετοχών και το ασφάλιστρο κινδύνου εξετάζει ο αμερικανικός οίκος.

Wall Street is cutting price targets on shares of NIO as the Chinese electric-vehicle maker cuts prices for its vehicles. Both items are potentially bad news for investors.

Chinook Therapeutics stock surged 66% in premarket trading Monday after Swiss pharmaceutical company Novartis agreed to buy the biopharma company for up to $3.5 billion.

A panel that reviews disputes in the credit default swaps market said on Friday that a ‘failure to pay’ credit event had not occurred in relation to Casino Guichard Perrachon, dashing investors’ hopes for a payout on the company’s CDS.

Anheuser-Busch InBev and Molson Coors Beverage are set to gain market share from craft beer makers in the United States this year as cost-conscious consumers are opting for cheaper six-packs, according to analysts and industry experts.

Global miner Glencore, Chrysler parent Stellantis and Volkswagen’s battery unit PowerCo have agreed to back a $1 billion deal by blank-cheque fund ACG Acquisition Company to buy two mines in Brazil, ACG said on Monday.

U.S. chipmaker Broadcom is set to gain conditional EU antitrust approval for its $61 billion proposed acquisition of cloud computing firm VMware, people familiar with the matter said.

Nasdaq on Monday said it will buy Thoma Bravo-owned software firm Adenza for $10.5 billion, in what would be the exchange operator’s biggest acquisition as it speeds up its push to become a more tech-focused company.

Shares of used-car retailer Carvana Co fell about 2% in premarket trading on Friday, as analysts fear that the debt-laden company’s upbeat second-quarter profit forecast could be just a ‘one-time’ gain.

AstraZeneca (AZN.L) said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.

Biogen and Eisai are headed back to face the Food and Drug Administration’s outside neurology experts, two and a half years after the same panel dealt what proved to be a decisive blow to their Alzheimer’s disease therapy, Aduhelm.